Trial
NCT02199223
Regorafenib + Panitumumab for Colorectal Cancers
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
KRAS and NRAS Wild-type Colorectal Cancer
Intervention
regorafenib + panitumumab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-22